Targeted therapies in renal cell cancer: recent developments in imaging

Targeted therapy has significantly improved the perspectives of patients with metastatic renal cell cancer (mRCC). Frequently, these new molecules cause disease stabilization rather than substantial tumor regression. As treatment options expand with the growing number of targeted agents, there is an...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Veldt, Astrid A. M., Meijerink, Martijn R., van den Eertwegh, Alfons J. M., Boven, Epie
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929340/
https://www.ncbi.nlm.nih.gov/pubmed/20625845
http://dx.doi.org/10.1007/s11523-010-0146-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929340/
https://www.ncbi.nlm.nih.gov/pubmed/20625845
http://dx.doi.org/10.1007/s11523-010-0146-5

Ejemplares similares